九强生物：关于九强转债恢复转股的提示性公告

Core Viewpoint - The company, Jiukang Biotechnology, announced a temporary suspension of the conversion of its convertible bonds due to the implementation of the second mid-term equity distribution for 2025, which will resume on November 27, 2025 [1] Group 1 - Jiukang Biotechnology's convertible bonds (code: 123150; abbreviation: Jiukang Convertible Bonds) will be suspended from conversion from November 19, 2025, until the equity registration date on November 26, 2025 [1] - The resumption of the bond conversion will take place on the first trading day after the equity registration date, specifically on November 27, 2025 [1]